The Quantellect read.As of Nov 19, 2026, 11 active firms cover BeiGene, Ltd: 11 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $367.00 to $459.00, so the covering firms are broadly aligned. The average target of $417.50 sits 4% above the current $403.38. The rating mix has stayed broadly stable, with Buy-side ratings easing from 13 to 11 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.01 next quarter toward $10.72 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Buy
Strong Buy00%
Buy11100%
Neutral00%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$417.50
+3.5% upside
Average target across 10 active firms as of Nov 19, 2026 vs $403.38 current
Highest Target$459.00
Average Target$417.50
Lowest Target$367.00
Detailed analyst forecasts for ONC
Showing 1–11 of 11 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 11 of 11 active firms rate ONC a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ONC EPS & revenue forecast
EPS · NEXT QUARTER
$2.01
Range $1.52 – $2.80 · 4 analysts · +3% YoY
Next period, 4 analysts expect BeiGene, Ltd. to earn $2.01 a share (range $1.52 – $2.80), versus $1.96 a year earlier. Full-year consensus is $9.87, growing to $10.72 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.7B – $1.8B · 4 analysts · +17% YoY
Revenue is expected to reach $1.8B (range $1.7B – $1.8B), +16.6% year-over-year. Full-year consensus is $6.9B, rising to $7.9B next year.
Top analysts covering BeiGene, Ltd.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ONC.
#1
Michael Schmidt
Guggenheim · Rank #4
Buy
$430.00+6.6% to target
Overall win rate
53%
+ Follow
#2
Leonid Timashev
RBC Capital · Rank #27
Buy
$465.00+15.3% to target
Overall win rate
52%
+ Follow
#3
Peter Lawson
Barclays · Rank #89
Buy
$407.00+0.9% to target
Overall win rate
45%
+ Follow
#4
Jessica Fye
JP Morgan · Rank #100
Buy
$445.00+10.3% to target
Overall win rate
54%
+ Follow
#5
Yigal Nochomovitz
Citigroup · Rank #381
Buy
$466.00+15.5% to target
Overall win rate
38%
+ Follow
ONC stock forecast FAQ
What is ONC's average 12-month price target?+
The 10 active firms with a live target average $417.50 for BeiGene, Ltd. over the next 12 months, ranging from a $459.00 high to a $367.00 low, as of Nov 19, 2026.
Is ONC stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 11 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ONC?+
The Street-high target is $459.00 (RBC Capital), and the Street-low is $367.00. The average of all 10 active-firm targets is $417.50.
How many active Wall Street firms cover ONC?+
11 active firms have a recognized rating on BeiGene, Ltd. as of Nov 19, 2026, and 10 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ONC?+
Among analysts who currently cover ONC, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #4). Their current call is Buy with a $430.00 target.
What is BeiGene, Ltd.'s projected EPS for next quarter?+
The consensus estimate is $2.01 per share (range $1.52 – $2.80) across 4 analysts. Full-year EPS is projected at $9.87, rising to $10.72 the following year.
How much revenue is BeiGene, Ltd. expected to report next quarter?+
Consensus revenue is $1.8B (range $1.7B – $1.8B). Full-year revenue is projected at $6.9B, growing to $7.9B next year.
Have analysts been upgrading or downgrading ONC lately?+
As of Nov 19, 2026, 11 of 11 active firms rate ONC a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ONC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.